Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study

BACKGROUND: Little is known about whether tolerability and adherence to treatment can be influenced by weather and temperature conditions. The objective of this study was to assess monthly and seasonal adherence to and safety of sc IFN-β1a (Rebif®, Merck) in relapsing-remitting multiple sclerosis (R...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Neurol
Glavni autori: Deftereos, Spyros N., Koutlas, Evangelos, Koutsouraki, Efrosini, Kyritsis, Athanassios, Papathanassopoulos, Panagiotis, Fakas, Nikolaos, Tsimourtou, Vaia, Vlaikidis, Nikolaos, Tavernarakis, Antonios, Voumvourakis, Konstantinos, Arvanitis, Michalis, Sakellariou, Dimitrios, DeLorenzo, Filippo
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6218994/
https://ncbi.nlm.nih.gov/pubmed/30400884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-018-1179-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items